| In vivo production of psilocybin in E. coli AM Adams, NA Kaplan, Z Wei, JD Brinton, CS Monnier, AL Enacopol, ... Metabolic engineering 56, 111-119, 2019 | 63 | 2019 |
| Improved immunoassay sensitivity and specificity using single-molecule colocalization AA Hariri, SS Newman, S Tan, D Mamerow, AM Adams, N Maganzini, ... Nature Communications 13 (1), 5359, 2022 | 20 | 2022 |
| Development of an E. coli-based norbaeocystin production platform and evaluation of behavioral effects in rats AM Adams, NA Anas, AK Sen, JD Hinegardner-Hendricks, PJ O’Dell, ... Metabolic Engineering Communications 14, e00196, 2022 | 13 | 2022 |
| Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli JE Flower, WJ Gibbons Jr, AM Adams, X Wang, CN Broude, JA Jones Biotechnology and Bioengineering 120 (8), 2214-2229, 2023 | 5 | 2023 |
| Evaluation of TrpM and PsiD substrate promiscuity reveals new biocatalytic capabilities FC Kanis, CN Broude, EB Hellwarth, WJ Gibbons Jr, AK Sen, AM Adams, ... Biotechnology Progress, e3492, 2024 | | 2024 |
| Theoretical framework and experimental validation of multiplexed analyte quantification using cross-reactive affinity reagents SS Newman, LA Hein, AM Adams, HT Soh bioRxiv, 2023.11. 24.568623, 2023 | | 2023 |
| Methods for the production of psilocybin and intermediates or side products JA Jones, A Adams, N Kaplan US Patent App. 17/755,368, 2022 | | 2022 |